144 related articles for article (PubMed ID: 24822208)
1. Urokinase gene 3'-UTR T/C polymorphism is associated with malignancy and ESRD in idiopathic membranous nephropathy.
Chen CH; Chen SY; Shu KH; Wen MC; Cheng CH; Wu MJ; Yu TM; Chuang YW; Tsai FJ
Biomed Res Int; 2014; 2014():425095. PubMed ID: 24822208
[TBL] [Abstract][Full Text] [Related]
2. Impact of plasminogen activator inhibitor-1 gene polymorphisms on primary membranous nephropathy.
Chen CH; Shu KH; Wen MC; Chen KJ; Cheng CH; Lian JD; Wu MJ; Yu TM; Tsai FJ
Nephrol Dial Transplant; 2008 Oct; 23(10):3166-73. PubMed ID: 18495745
[TBL] [Abstract][Full Text] [Related]
3. Urokinase Plasminogen Activator Deficiency Aggravates Cationic Bovine Serum Albumin-Induced Membranous Nephropathy Through T Helper Cell Type 2-Prone Immune Response in Mice.
Jao TM; Wu CZ; Cheng CW; Guo CH; Bai CY; Chang LC; Fang TC; Chen JS
Lab Invest; 2023 Jul; 103(7):100146. PubMed ID: 37004912
[TBL] [Abstract][Full Text] [Related]
4. A C/T polymorphism in the urokinase-type plasminogen activator gene in colorectal cancer.
Przybylowska K; Smolarczyk K; Blasiak J; Kulig A; Romanowicz-Makowska H; Dziki A; Ulanska J; Pander B
J Exp Clin Cancer Res; 2001 Dec; 20(4):569-72. PubMed ID: 11876553
[TBL] [Abstract][Full Text] [Related]
5. Correlation analysis of angiotensin-converting enzyme, angiotensinogen, and endothelial nitric oxide synthase gene polymorphisms and the progression of immunoglobulin A nephropathy/membranous nephropathy.
Zhu X; Kong D; Zhang L; Sun Y; Na S; Han C; Jin X
Hum Pathol; 2013 Dec; 44(12):2806-13. PubMed ID: 24157068
[TBL] [Abstract][Full Text] [Related]
6. Single nucleotide polymorphisms in the phospholipase A2 receptor gene are associated with genetic susceptibility to idiopathic membranous nephropathy.
Kim S; Chin HJ; Na KY; Kim S; Oh J; Chung W; Noh JW; Lee YK; Cho JT; Lee EK; Chae DW;
Nephron Clin Pract; 2011; 117(3):c253-8. PubMed ID: 20805699
[TBL] [Abstract][Full Text] [Related]
7. Antigen levels of the urokinase-type plasminogen activator and its gene polymorphisms in colorectal cancer.
Przybyłowska K; Smolarczyk K; Kulig A; Romanowicz-Makowska H; Dziki A; Ulańska J; Pander B; Błasiak J
Cancer Lett; 2002 Jul; 181(1):23-30. PubMed ID: 12430175
[TBL] [Abstract][Full Text] [Related]
8. The CTLA-4 +49GG genotype is associated with susceptibility for nephrotic kidney diseases.
Spink C; Stege G; Tenbrock K; Harendza S
Nephrol Dial Transplant; 2013 Nov; 28(11):2800-5. PubMed ID: 23975748
[TBL] [Abstract][Full Text] [Related]
9. Association of urokinase gene 3'-UTR T/C polymorphism with calcium oxalate urolithiasis in children.
Ozturk M; Kordan Y; Cangul H; Dogan HS; Kilicarslan H; Vuruskan H; Oktay B
Int Urol Nephrol; 2008; 40(3):563-8. PubMed ID: 18240004
[TBL] [Abstract][Full Text] [Related]
10. Gene polymorphism and risk of idiopathic membranous nephropathy.
Liu D; Zhang J; Shi Y; Liu Z
Life Sci; 2019 Jul; 229():124-131. PubMed ID: 31075233
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of urokinase-type plasminogen activator genotypes in gastric cancer.
Wu CY; Wu MS; Chen YJ; Chen HP; Chen CJ; Chang CS; Lin JT
Hepatogastroenterology; 2008; 55(86-87):1890-4. PubMed ID: 19102416
[TBL] [Abstract][Full Text] [Related]
12. [Paraneoplastic membranous nephropathy].
Romanov VP; Klopotskiĭ SA
Klin Med (Mosk); 2006; 84(6):59-61. PubMed ID: 16875073
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the association of urokinase plasminogen activator system gene polymorphisms with susceptibility and pathological development of hepatocellular carcinoma.
Weng CJ; Tsai CM; Chen YC; Hsieh YH; Lin CW; Liu YF; Su SC; Chen MK; Yang SF
Ann Surg Oncol; 2010 Dec; 17(12):3394-401. PubMed ID: 20706793
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphism of the plasminogen activator inhibitor-1 is associated with an increased risk of endometrial cancer.
Su CK; Yeh KT; Yeh CB; Wang PH; Ho ES; Chou MC; Liu KC; Yang SF; Yi YC
J Surg Oncol; 2011 Dec; 104(7):755-9. PubMed ID: 21761413
[TBL] [Abstract][Full Text] [Related]
15. High expression of the urokinase plasminogen activator and its cognate receptor associates with advanced stages and reduced disease-free interval in papillary thyroid carcinoma.
Ulisse S; Baldini E; Sorrenti S; Barollo S; Gnessi L; Catania A; Pellizzo MR; Nardi F; Mian C; De Antoni E; D'Armiento M; Frati L
J Clin Endocrinol Metab; 2011 Feb; 96(2):504-8. PubMed ID: 21106716
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphism of urokinase-type plasminogen activator is interacting with plasminogen activator inhibitor-1 to raise risk of cervical neoplasia.
Tee YT; Wang PH; Tsai HT; Lin LY; Lin HT; Yang SF; Hsieh YH; Ying TH
J Surg Oncol; 2012 Aug; 106(2):204-8. PubMed ID: 22354580
[TBL] [Abstract][Full Text] [Related]
17. Urokinase gene 3'-UTR T/C polymorphism is associated with urolithiasis.
Tsai FJ; Lin CC; Lu HF; Chen HY; Chen WC
Urology; 2002 Mar; 59(3):458-61. PubMed ID: 11880102
[TBL] [Abstract][Full Text] [Related]
18. Phosphotriesterase-related protein sensed albuminuria and conferred renal tubular cell activation in membranous nephropathy.
Cheng CW; Chang LC; Tseng TL; Wu CC; Lin YF; Chen JS
J Biomed Sci; 2014 Apr; 21(1):32. PubMed ID: 24750591
[TBL] [Abstract][Full Text] [Related]
19. Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association.
Lefaucheur C; Stengel B; Nochy D; Martel P; Hill GS; Jacquot C; Rossert J;
Kidney Int; 2006 Oct; 70(8):1510-7. PubMed ID: 16941021
[TBL] [Abstract][Full Text] [Related]
20. Lack of association between transient receptor potential cation channel 6 polymorphisms and primary membranous glomerulonephritis.
Chen WC; Chen SY; Chen CH; Chen HY; Lin YW; Ho TJ; Huang YC; Shen JL; Tsai FJ; Chen YH
Ren Fail; 2010 Jul; 32(6):666-72. PubMed ID: 20540633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
